http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022162274-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc07e04ec706929a37607ca414fb9065 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-102 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
filingDate | 2020-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4263773b5f057a3956481fc6929bd34d |
publicationDate | 2022-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2022162274-A1 |
titleOfInvention | Production and uses of artifical histone h1 for analyzing, diagnosing, treating, and/or preventing senescence |
abstract | The present invention provides a method for producing artificial protein sequences and artificial nucleic acid sequences for the linker histone variants H1.0 (also known as histone H1°; H1(0); H5; H1δ; RI H1; or H1 histone family, member 0) and H1x (also known as histone H1.10 or H1 histone family, member X). In particular, the artificial protein sequences produced by the method feature engineered α-helical motifs—three structural motifs in the histone H1 that bind to nucleosomal and/or linker DNA in chromatin. These artificial-sequence histone H1 proteins, when they replace or supplement their wild-type counterparts in vivo, confer multicellular individuals significant resistance to senescence and/or age-related health conditions such as age-related cancer. |
priorityDate | 2019-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 174.